leisure time -WSS

leisure time

author：knowledge 2025-09-06 06:16:36 - browse：1562

WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： STAT Summit: Biotech founders on deal

Wikipedia

WSS

Ascension's ugly legal battle over care for poor patients in Texas

NIH confirmation hearing shows politicization of research

UnitedHealth’s board chair also owns a personal investment firm

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Merck to acquire Harpoon Therapeutics for $680 million

Gene therapy denied for Afghan refugee whose father aided U.S.

entertainment

leisure time

hotspot

Bright Health sells Medicare Advantage business to Molina

Pharmacists can make shortage drugs, but at what cost?

The high cost of giving birth even with insurance

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Jerome Adams on the need for new antivirals for Covid

Lawmakers consider Medicare pay reforms for doctors

Virginia high school admissions case could be legal follow

Merck to acquire Harpoon Therapeutics for $680 million

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

focus

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Physician assistants need a new name. Here's what it should be

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

FDA early review: GLP

STAT Summit: Michael J. Fox on progress in Parkinson's research

Beam Therapeutics to lay off 20% of its staff, re

Wikipedia

knowledge

focus

focus